 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Revolution Medicines announced the publication of a peer-reviewed research paper in 'Cancer Discovery' detailing the discovery and preclinical to clinical translation for RMC-6236 on Monday. The...

What's Going On With Revolution Medicines Stock?

Futures On Edge Ahead Of Critical CPI Report

 Futures are up small before the March CPI data was expected to show further moderation in price pressures following stronger readings at the...

Futures On Edge Ahead Of Critical CPI Report

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) has been given an average recommendation of "Buy" by the ten brokerages that are presently covering the firm, Marketbeat reports. Ten...

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $38.80 Consensus Target Price from Analysts

REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines to Participate in Upcoming Investor Conferences

This indicator may be signaling RVMD's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Revolution Medicines (RVMD, $32.2) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

REDWOOD CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024

Semper Paratus Acquisition (NASDAQ:LGST  Get Free Report) and Revolution Medicines (NASDAQ:RVMD  Get Free Report) are both medical companies, but which is the superior business? We will...

Revolution Medicines (NASDAQ:RVMD) vs. Semper Paratus Acquisition (NASDAQ:LGST) Financial Survey

Revolution Medicines, Inc. (NASDAQ:RVMD  Get Free Report) COO Margaret A. Horn sold 2,914 shares of the firms stock in a transaction on Monday, March 18th. The stock was sold at an...

Insider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) COO Sells $92,024.12 in Stock

Revolution Medicines, Inc. (NASDAQ:RVMD  Get Free Report) insider Stephen Michael Kelsey sold 2,123 shares of the businesss stock in a transaction dated Monday, March 18th. The shares...

Stephen Michael Kelsey Sells 2,123 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) Stock

Hudson Bay Capital Management LP lessened its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD  Free Report) by 82.2% during the 3rd quarter, according to the company in its most...

Revolution Medicines, Inc. (NASDAQ:RVMD) Position Trimmed by Hudson Bay Capital Management LP

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Volume (M)	1.24M
52-Wk High	$38.73
52-Wk Low	$15.44

RVMD Revolution Medicines Inc

About

Feed

News

Sentiment

Earnings

Fundamentals